Search results
Results from the WOW.Com Content Network
Talazoparib, sold under the brand name Talzenna, is an anti-cancer medication used for the treatment of breast cancer and prostate cancer. [6] It is an orally available poly ADP ribose polymerase PARP inhibitor marketed by Pfizer for the treatment of advanced breast cancer with germline BRCA mutations. [9]
Steps 1 and 3 require the input of energy derived from the hydrolysis of ATP to ADP and P i (inorganic phosphate), whereas steps 7 and 10 require the input of ADP, each yielding ATP. [7] The enzymes necessary to break down glucose are found in the cytoplasm , the viscous fluid that fills living cells, where the glycolytic reactions take place.
In establishing this Charter, we declare a political system and civil administration founded upon a social contract that reconciles the rich mosaic of Syria through a transitional phase from dictatorship, civil war and destruction, to a new democratic society where civic life and social justice are preserved.
Cangrelor, sold under the brand name Kengreal among others, is a P2Y 12 inhibitor FDA approved as of June 2015 as an antiplatelet drug [5] for intravenous application. Some P2Y 12 inhibitors are used clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation. [5]
AOL latest headlines, entertainment, sports, articles for business, health and world news.
The appointment of ADGPs is typically made by the state government. According to Section 5 of the Police Act in some states: The State Government may appoint one or more Additional Director Generals, Inspector Generals, Deputy and Assistant Inspector Generals of Police as necessary.
P2Y 12 is a chemoreceptor for adenosine diphosphate (ADP) [5] [6] that belongs to the G i class of a group of G protein-coupled (GPCR) purinergic receptors. [7] This P2Y receptor family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides.
The molecular target of the active metabolite of ADP receptor inhibitors is the P2Y 12 receptor. [17] P2Y 12 receptor is a G-coupled receptor and is activated by adenosine diphosphate. ADP binds to the P2Y 12 receptor that leads to inhibition of adenyl cyclase and thereby decreases the intracellular